Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 442

1.

Practical management of patients on Janus kinase inhibitor (JAKi) therapy: Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR).

Richez C, Morel J, Cornec D, Daïen C, Goupille P, Lazaro E, Lequerré T, Nocturne G, de Lédinghen V, Le Goff B, Pourcher V, Prati C, Seror R, Tournadre A, Truchetet ME, Sibilia J, Pham T.

Joint Bone Spine. 2019 Oct;86 Suppl 1:eS2-eS103. doi: 10.1016/S1297-319X(19)30154-X. Epub 2019 Oct 31. No abstract available.

PMID:
31791545
2.

Practical management of patients on Janus kinase inhibitor (JAKi) therapy - the CRI fact sheets.

Richez C, Morel J, Sibilia J, Pham T; In the name of the CRI and the team of expert authors.

Joint Bone Spine. 2019 Oct;86 Suppl 1:eS1. doi: 10.1016/S1297-319X(19)30153-8. Epub 2019 Oct 31. No abstract available.

PMID:
31791544
3.

Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis.

Virone A, Bastard JP, Fellahi S, Capeau J, Rouanet S, Sibilia J, Ravaud P, Berenbaum F, Gottenberg JE, Sellam J.

RMD Open. 2019 Jul 21;5(2):e000897. doi: 10.1136/rmdopen-2019-000897. eCollection 2019.

4.

T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.

Poindron V, Chatelus E, Canuet M, Gottenberg JE, Arnaud L, Gangi A, Gavand PE, Guffroy A, Korganow AS, Germain P, Sibilia J, El Ghannudi S, Martin T.

Semin Arthritis Rheum. 2019 Jun 19. pii: S0049-0172(18)30711-X. doi: 10.1016/j.semarthrit.2019.06.013. [Epub ahead of print]

5.

Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes.

Spielmann L, Nespola B, Séverac F, Andres E, Kessler R, Guffroy A, Poindron V, Martin T, Geny B, Sibilia J, Meyer A.

Ann Rheum Dis. 2019 Aug;78(8):1101-1106. doi: 10.1136/annrheumdis-2018-214439. Epub 2019 May 24.

PMID:
31126956
6.

Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.

Bykerk VP, Östör AJK, Alvaro-Gracia J, Pavelka K, Román Ivorra JA, Nurmohamed MT, Luder Y, Sidiropoulos PNM, Devenport J, Sibilia J.

Clin Rheumatol. 2019 Sep;38(9):2411-2421. doi: 10.1007/s10067-019-04535-z. Epub 2019 Apr 26.

PMID:
31028551
7.

The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database.

Sebbag E, Felten R, Sagez F, Sibilia J, Devilliers H, Arnaud L.

Ann Rheum Dis. 2019 Jun;78(6):844-848. doi: 10.1136/annrheumdis-2019-215142. Epub 2019 Apr 15.

PMID:
30987966
8.

[Periodic certification of physicians for personalized professional development].

Sibilia J.

Rev Prat. 2019 Feb;69(2):135-136. Review. French. No abstract available.

PMID:
30983209
9.

The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.

Felten R, Scher F, Sibilia J, Gottenberg JE, Arnaud L.

Autoimmun Rev. 2019 Jun;18(6):576-582. doi: 10.1016/j.autrev.2018.12.008. Epub 2019 Apr 6.

PMID:
30959220
10.

The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis.

Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Jouen F, Joly P, Marie I, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O; OncoMyositis Study Group.

Arthritis Rheumatol. 2019 Aug;71(8):1360-1370. doi: 10.1002/art.40895. Epub 2019 Jul 8.

PMID:
30896088
11.

Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.

Matuszak J, Blondet C, Hubelé F, Gottenberg JE, Sibilia J, Bund C, Geny B, Namer IJ, Meyer A.

Rheumatology (Oxford). 2019 Mar 8. pii: kez040. doi: 10.1093/rheumatology/kez040. [Epub ahead of print]

PMID:
30851092
12.

Revisiting the Association Between Systemic Lupus Erythematosus and Gout.

Aguiar F, Brito I, Sibilia J.

Reumatol Clin. 2019 Mar 2. pii: S1699-258X(19)30029-4. doi: 10.1016/j.reuma.2019.01.001. [Epub ahead of print] English, Spanish. No abstract available.

13.

Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.

Arnaud L, Mertz P, Gavand PE, Martin T, Chasset F, Tebacher-Alt M, Lambert A, Muller C, Sibilia J, Lebrun-Vignes B, Salem JE.

Ann Rheum Dis. 2019 Apr;78(4):504-508. doi: 10.1136/annrheumdis-2018-214598. Epub 2019 Feb 4.

PMID:
30793701
14.

Strategy for suspected myositis.

Meyer A, Sibilia J.

Joint Bone Spine. 2019 Oct;86(5):568-575. doi: 10.1016/j.jbspin.2019.01.013. Epub 2019 Feb 1.

PMID:
30711692
15.

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study.

Gottenberg JE, Morel J, Perrodeau E, Bardin T, Combe B, Dougados M, Flipo RM, Saraux A, Schaeverbeke T, Sibilia J, Soubrier M, Vittecoq O, Baron G, Constantin A, Ravaud P, Mariette X; French Society of Rheumatology and the investigators participating in AIR, ORA, and REGATE registries.

BMJ. 2019 Jan 24;364:l67. doi: 10.1136/bmj.l67.

16.

Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study.

Grimaud F, Yelnik C, Pineton de Chambrun M, Amoura Z, Arnaud L, Costedoat Chalumeau N, Hachulla E, Lambert M, Roriz M, Sibilia J, Papo T, Sacre K.

Rheumatology (Oxford). 2019 Jun 1;58(6):1006-1010. doi: 10.1093/rheumatology/key437.

PMID:
30608611
17.

Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature.

Arnaud L, Gavand PE, Voll R, Schwarting A, Maurier F, Blaison G, Magy-Bertrand N, Pennaforte JL, Peter HH, Kieffer P, Bonnotte B, Poindron V, Fiehn C, Lorenz H, Amoura Z, Sibilia J, Martin T.

Rheumatology (Oxford). 2019 Jun 1;58(6):987-996. doi: 10.1093/rheumatology/key398.

PMID:
30597077
18.

Mechanics hands in patients with antisynthetase syndrome: 25 cases.

Gusdorf L, Morruzzi C, Goetz J, Lipsker D, Sibilia J, Cribier B.

Ann Dermatol Venereol. 2019 Jan;146(1):19-25. doi: 10.1016/j.annder.2018.11.010. Epub 2018 Dec 28.

PMID:
30595338
19.

Trained Immunity and Autoimmune Disease: Did Eve Sin before Adam?

Berthelot JM, Sibilia J.

Joint Bone Spine. 2019 May;86(3):293-295. doi: 10.1016/j.jbspin.2018.12.006. Epub 2018 Dec 22. No abstract available.

PMID:
30584920
20.

The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis.

Mertz P, Belot A, Cervera R, Chuah TY, Dagna L, Damian L, Danda D, D'cruz D, Espinosa G, Frances C, Jayne D, Ooi KK, Kucharz EJ, Lebovics R, Marie I, Moulis G, Peng S, Sharma A, Suzuki N, Tanaka T, Van Vollenhoven R, Sibilia J, Gottenberg JE, Chasset F, Arnaud L.

Joint Bone Spine. 2019 May;86(3):363-368. doi: 10.1016/j.jbspin.2018.11.001. Epub 2018 Nov 15.

PMID:
30448476

Supplemental Content

Loading ...
Support Center